Is multiple sclerosis hereditary?

Multiple sclerosis (MS) is a disease of the central nervous system (brain and spinal cord). The cause of MS is not known, but scientists believe MS is triggered by some combination of these factors: immunologic, environmental, infectious, and genetic. If you live with MS and also have a family (or plan on starting one), you might be wondering if MS is passed down from generation to generation. We ...

Continue reading

Do you have a COPD action plan?

COPD, short for chronic obstructive pulmonary disease, is a chronic inflammatory lung disease that causes obstructed airflow from the lungs. More than 16 million Americans are living with COPD, and millions more have it but don’t know it. Signs of COPD include ongoing cough, shortness of breath, lots of mucus, and chest tightness — but everyone will experience this disease differently.

Continue reading

What your team should look like: Clinical trials vendor guide

The goal of any clinical trial should be to provide the best journey for the patient from start to finish. In order to achieve this, a sponsor will collaborate with an array of vendors to handle everything from pre-recruitment to site follow-up. Statistics on outsourcing vary, but largely tell the same story of an upward trend. Big pharma outsources around 40-45% of their activities to contract ...

Continue reading

Three new research recruitment strategies to try this year

The beginning of the year is an optimal time to review your clinical trial recruitment strategies and brainstorm new ones. The best clinical trial recruitment strategies start by focusing on the patient voice and perspective, and from there, it helps to get creative. We share three new research recruitment strategies to try this year.

Continue reading

Five accounts to follow on social media if you're interested in COPD

Chronic pulmonary obstructive disease, commonly referred to as COPD, is a chronic inflammatory lung disease that causes obstructed airflow from the lungs. It affects more than 16 million Americans, and millions more have it but don’t know it. At Antidote, we believe in the power of the patient voice to provide inspiration and hope to others in similar situations. Social media networks have become ...

Continue reading

An interview with our partner, Allergy & Asthma Network

Allergy & Asthma Network (AAN) is a leading nonprofit in asthma, allergies, and related conditions. They’re a patient-centered network uniting individuals, families, healthcare professionals, industry leaders, and government decision-makers to improve health and quality of life for the millions of people affected by these conditions. We’re proud to partner with them to help people living with ...

Continue reading

COPD research round-up

More than 16 million Americans have chronic obstructive pulmonary disease, commonly referred to as COPD, and millions more have it but don’t know it. COPD is a chronic inflammatory lung disease that causes obstructed airflow from the lungs.

Continue reading

3 best practices for clinical trial marketing

Social media. Interstitial video ads. Native banner placements. Paid search. Radio spots. TV commercials. Newspaper and magazine spreads. These days, there are so many ways to think about marketing. With the marketing landscape ever-changing, contract research organizations (CROs) and pharmaceutical sponsors often work with clinical trial recruitment companies to reach people interested in ...

Continue reading

Damian Washington shares his multiple sclerosis story

You’ve probably seen Damian Washington in a commercial on TV or somewhere on the internet. He appeared in a Ring.com commercial with the legendary Shaquille O’Neal, starred in a very funny Chex Mix commercial featuring a metal detector and a beach, and played a Lowe’s employee named Jim who helps a couple find not only lightbulbs for their home, but an entire patio set, too. Damian does ...

Continue reading

Decentralizing research: How reducing patient burden improves trial diversity [whitepaper]

Could the alternative clinical trial approaches necessitated by the COVID-19 pandemic help tip the scales towards fair access to clinical trials? In our latest whitepaper, “Decentralizing research: How reducing patient burden improves trial diversity,” we take a close look at the current state of diversity in clinical trials, then explore how the decreased participant burden of decentralized ...

Continue reading

Get our latest posts in your inbox